PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Drug, Healthcare and Patient Safety10.2147/dhps.s18389220182018103-108Ceftriaxone-associated nephrolithiasis and gallstone in adultsGhodsiye Azarkar, Motahare Mahi Birjand, Alireza Ehsanbakhsh, Bita Bijari, Mohammad Reza Abedini, Masood Ziaeehttps://www.dovepress.com/getfile.php?fileID=46910, https://www.dovepress.com/getfile.php?fileID=46910
Journal of Infection and Chemotherapy10.1016/j.jiac.2019.05.0202019201912972-978Experimental verification of factors influencing calcium salt formation based on a survey of the development of ceftriaxone-induced gallstone-related disorderRui Ito, Asami Yoshida, Kazuaki Taguchi, Yuki Enoki, Yuta Yokoyama, Kazuaki Matsumotohttps://api.elsevier.com/content/article/PII:S1341321X19301527?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1341321X19301527?httpAccept=text/plain
Journal of Clinical Pharmacy and Therapeutics10.1111/j.1365-2710.2011.01321.x201120114448-451Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance CentreG. Shalviri, S. Yousefian, K. Gholamihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2710.2011.01321.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.2011.01321.x/fullpdf
Transfusion10.1111/j.1537-2995.2004.03378.x2004200471033-1040Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cellsBeatrice Gro├čjohann, Petra Eichler, Andreas Greinacher, Sentot Santoso, Hartmut Krollhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1537-2995.2004.03378.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1537-2995.2004.03378.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2004.03378.x/fullpdf
Transfusion10.1111/trf.14536201820184879-883Ceftriaxone-induced drug reaction mimicking acute splenic sequestration crisis in a child with hemoglobin SC diseaseNancy L. Van Buren, Jed B. Gorlin, Robyn C. Reed, Jerome L. Gottschall, Stephen C. Nelsonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Ftrf.14536, http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14536/fullpdf
Transfusion10.1111/j.1537-2995.2011.03321.x201120113602-612Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia (CME)Patricia A. Arndt, Regina M. Leger, George Garrattyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1537-2995.2011.03321.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2011.03321.x/fullpdf
Reactions Weekly10.1007/s40278-022-22457-3202220221172-172Ceftriaxonehttps://link.springer.com/content/pdf/10.1007/s40278-022-22457-3.pdf, https://link.springer.com/article/10.1007/s40278-022-22457-3/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-22457-3.pdf
Reactions Weekly10.1007/s40278-022-07853-1202220221188-188Ceftriaxonehttps://link.springer.com/content/pdf/10.1007/s40278-022-07853-1.pdf, https://link.springer.com/article/10.1007/s40278-022-07853-1/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-07853-1.pdf
Reactions Weekly10.1007/s40278-018-49447-3201820181158-158Ceftriaxonehttp://link.springer.com/content/pdf/10.1007/s40278-018-49447-3.pdf, http://link.springer.com/article/10.1007/s40278-018-49447-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-49447-3.pdf
Reactions Weekly10.1007/s40278-022-09079-920222022182-82Ceftriaxonehttps://link.springer.com/content/pdf/10.1007/s40278-022-09079-9.pdf, https://link.springer.com/article/10.1007/s40278-022-09079-9/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-09079-9.pdf